Company Introduction

T-ACE Medical Co. is established in Tainan, Taiwan on August 7, 2018, as the brainchild of the research team led by Dr. Xi-Zhang Lin, College of Medicine, National Cheng-Kung University. The innovation was sponsored by Ministry of Science and Technology, Taiwan.
T-ACE Medical Co. is committed to innovate the minimally-invasive technologies for patients suffering from serious illness.
 
大員生醫是專門針對肝膽腸胃科及消化道系統，提供診斷輔助、介入性治療的複合醫材研發公司。 團隊成員由成功大學、成大醫院、工研院及食品所等專家組成，以醫師身為使用者的經驗為出發點，將「在病床邊看到的問題」化為研發動能，為醫療團隊及病人打造有效幫助清除病灶且價格合理的介入性治療複合醫療器材。

Brief description of main products or services 

1. T-AceGel is a class II medical device that is used as a submucosa-lifting agent. T-AceGel can facilitate gastrointestinal endoscopic procedures for removing polyps, adenomas, early–stage cancers, or other suspected lesions in gastrointestinal tract. When T-AceGel is injected under the mucosa of a lesion, it immediately creates a long-lasting lift with a colored cushion, separating the mucosa from the submucosa. This offers increased visibility of target lesion margins and empowers endoscopists to perform resections or dissections safely and efficiently.
2. T-ACE Oil, developed by our joint venture with Food Industry Research and Development Institute, is a mixture of iodinated fatty acid ethyl esters derived from sunflower seed oil. It carries the same chemical components and physical properties as the current commercially available iodized oil that was made from poppy seeds. T-ACE Oil is an ideal tool for kinds of vascular interventions, especially for the application of trans-arterial chemoembolization (TACE) for liver cancers.
3. T-ACE Beads is classified as a Class III medical device. It is a new generation of drug-loaded beads, used in tandem with trans-arterial chemo-embolization (TACE). T-ACE Beads can also be developed into a comprehensive embolism bead system (including general beads, drug-loaded beads, and radioactive beads).